Search details
1.
Distribution and prognostic role of BRCA status in elderly ovarian cancer patients.
Gynecol Oncol
; 182: 57-62, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38262239
2.
Epithelial ovarian cancer and brain metastases: might the BRCA status, PARP inhibitor administration, and surgical treatment impact the survival?
Int J Gynecol Cancer
; 34(1): 88-98, 2024 Jan 05.
Article
in English
| MEDLINE | ID: mdl-38805344
3.
The Pathogenic RET Val804Met Variant in Acromegaly: A New Clinical Phenotype?
Int J Mol Sci
; 25(3)2024 Feb 05.
Article
in English
| MEDLINE | ID: mdl-38339173
4.
Multiple Sclerosis Onset before and after COVID-19 Vaccination: Can HLA Haplotype Be Determinant?
Int J Mol Sci
; 25(8)2024 Apr 22.
Article
in English
| MEDLINE | ID: mdl-38674141
5.
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study.
BMC Cancer
; 23(1): 540, 2023 Jun 13.
Article
in English
| MEDLINE | ID: mdl-37312079
6.
Unexpected finding of a rare pathogenic germline BRCA1 variant in an intrahepatic cholangiocarcinoma using the Oncomine Focus DNA assay: clinical and diagnostic implications.
Mol Biol Rep
; 50(8): 7113-7120, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37340184
7.
Ovarian cancer onset across different BRCA mutation types: a view to a more tailored approach for BRCA mutated patients.
Int J Gynecol Cancer
; 33(2): 257-262, 2023 02 06.
Article
in English
| MEDLINE | ID: mdl-36581488
8.
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors.
Int J Gynecol Cancer
; 33(6): 922-928, 2023 06 05.
Article
in English
| MEDLINE | ID: mdl-36759000
9.
Triple Genetic Diagnosis in a Patient with Late-Onset Leukodystrophy and Mild Intellectual Disability.
Int J Mol Sci
; 25(1)2023 Dec 29.
Article
in English
| MEDLINE | ID: mdl-38203665
10.
Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early-stage endometrial cancer: A propensity score-matched analysis.
Cancer
; 128(15): 2898-2907, 2022 08 01.
Article
in English
| MEDLINE | ID: mdl-35617463
11.
A novel low-density lipoprotein receptor variant in a Ukrainian patient: a case report and overview of the disease-causing low-density lipoprotein receptor variants associated to familial hypercholesterolemia.
Mol Biol Rep
; 49(2): 1623-1630, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34846648
12.
BRCA testing on buccal swab to improve access to healthcare and cancer prevention: a performance evaluation.
Int J Gynecol Cancer
; 2022 Aug 26.
Article
in English
| MEDLINE | ID: mdl-36028233
13.
Deep-Learning to Predict BRCA Mutation and Survival from Digital H&E Slides of Epithelial Ovarian Cancer.
Int J Mol Sci
; 23(19)2022 Sep 26.
Article
in English
| MEDLINE | ID: mdl-36232628
14.
Glucose-6-phosphate dehydrogenase deficiency and hydroxychloroquine in the COVID-19 era: a mini review.
Mol Biol Rep
; 48(3): 2973-2978, 2021 Mar.
Article
in English
| MEDLINE | ID: mdl-33620659
15.
The BRCA1 c.788G > T (NM_007294.4) variant in a high grade serous ovarian cancer (HGSOC) patient: foods for thought.
Mol Biol Rep
; 48(3): 2985-2992, 2021 Mar.
Article
in English
| MEDLINE | ID: mdl-33656647
16.
BRCA testing delay during the COVID-19 pandemic: How to act?
Mol Biol Rep
; 48(1): 983-987, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-33313973
17.
Tumor BRCA testing in ovarian cancer and EQA scheme: our experience of a critical evaluation.
Mol Biol Rep
; 48(12): 8203-8209, 2021 Dec.
Article
in English
| MEDLINE | ID: mdl-34643925
18.
Duplex high resolution melting analysis (dHRMA) to detect two hot spot CYP24A1 pathogenic variants (PVs) associated to idiopathic infantile hypercalcemia (IIH).
Mol Biol Rep
; 48(4): 3303-3311, 2021 Apr.
Article
in English
| MEDLINE | ID: mdl-33864587
19.
Feasibility of tumor testing for BRCA status in high-grade serous ovarian cancer using fresh-frozen tissue based approach.
Gynecol Oncol
; 158(3): 740-746, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32553590
20.
BRCA testing in a genomic diagnostics referral center during the COVID-19 pandemic.
Mol Biol Rep
; 47(6): 4857-4860, 2020 Jun.
Article
in English
| MEDLINE | ID: mdl-32388698